AU7622396A - Therapeutic agents and screening method - Google Patents

Therapeutic agents and screening method

Info

Publication number
AU7622396A
AU7622396A AU76223/96A AU7622396A AU7622396A AU 7622396 A AU7622396 A AU 7622396A AU 76223/96 A AU76223/96 A AU 76223/96A AU 7622396 A AU7622396 A AU 7622396A AU 7622396 A AU7622396 A AU 7622396A
Authority
AU
Australia
Prior art keywords
therapeutic agents
screening method
screening
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76223/96A
Inventor
Mira Susa Spring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU7622396A publication Critical patent/AU7622396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
AU76223/96A 1995-11-22 1996-11-11 Therapeutic agents and screening method Abandoned AU7622396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95810728 1995-11-22
EP95810728 1995-11-22
PCT/EP1996/004913 WO1997019352A1 (en) 1995-11-22 1996-11-11 Therapeutic agents and screening method

Publications (1)

Publication Number Publication Date
AU7622396A true AU7622396A (en) 1997-06-11

Family

ID=8221820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76223/96A Abandoned AU7622396A (en) 1995-11-22 1996-11-11 Therapeutic agents and screening method

Country Status (2)

Country Link
AU (1) AU7622396A (en)
WO (1) WO1997019352A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186979A1 (en) * 1996-10-02 1998-04-02 Michael Dennis Methods of testing antagonists for their abilities to affect the activity of g protein-coulpled receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins

Also Published As

Publication number Publication date
WO1997019352A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
GB9711208D0 (en) Therapeutic structure and method
AUPN698495A0 (en) Improved therapeutic formulation and method
AU5268696A (en) Novel compounds and methods for therapy
AU7125198A (en) Defibrillator method and apparatus
AU6591796A (en) Audiometric apparatus and associated screening method
AU2035195A (en) Electroheating apparatus and methods
AU6584296A (en) Well completion system and method
AU7053896A (en) Completion apparatus and method
EP0851759A4 (en) Compounds and methods
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU8700798A (en) Intravascular apparatus and method
AU6854196A (en) Lighting apparatus and method
GB9504495D0 (en) Method and composition
AU6527496A (en) Anchoring apparatus and method
AU5949296A (en) Reminder apparatus and method
AU6480696A (en) Quilting method and apparatus
AU7633596A (en) Control methods and apparatus
EP0836617A4 (en) Parevins and tachytegrins
GB9515868D0 (en) Therapeutic method
AU5386396A (en) Mfc-quick change method and apparatus
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AUPN137895A0 (en) Composition and method
AU7065498A (en) Acoustic apparatus and method
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU5188296A (en) Carbopeptoids and carbonucleotoids